These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
480 related articles for article (PubMed ID: 22271811)
1. Imaging modalities for the staging of patients with colorectal cancer. Bipat S; Niekel MC; Comans EF; Nio CY; Bemelman WA; Verhoef C; Stoker J Neth J Med; 2012 Jan; 70(1):26-34. PubMed ID: 22271811 [TBL] [Abstract][Full Text] [Related]
2. Imaging and treatment of patients with colorectal liver metastases in the Netherlands: a survey. Bipat S; van Leeuwen MS; Ijzermans JN; Bossuyt PM; Greve JW; Stoker J Neth J Med; 2006 May; 64(5):147-51. PubMed ID: 16702613 [TBL] [Abstract][Full Text] [Related]
3. Controversies in the management of colorectal liver metastases: role of PET and PET/CT. Wiering B; Vogel WV; Ruers TJ; Oyen WJ Dig Surg; 2008; 25(6):413-20. PubMed ID: 19212113 [TBL] [Abstract][Full Text] [Related]
4. Imaging strategies before beginning treatment of colorectal liver metastases. Legou F; Chiaradia M; Baranes L; Pigneur F; Zegai B; Djabbari M; Calderaro J; Laurent A; Kobeiter H; Rahmouni A; Luciani A Diagn Interv Imaging; 2014 May; 95(5):505-12. PubMed ID: 24794793 [TBL] [Abstract][Full Text] [Related]
5. Role of 18F-fluorodeoxyglucose positron emission tomography in detecting extrahepatic metastasis in pretreatment staging of hepatocellular carcinoma. Yoon KT; Kim JK; Kim DY; Ahn SH; Lee JD; Yun M; Rha SY; Chon CY; Han KH Oncology; 2007; 72 Suppl 1():104-10. PubMed ID: 18087190 [TBL] [Abstract][Full Text] [Related]
6. The accuracy of computed tomography in the pretreatment staging of colorectal cancer. Tan YN; Li XF; Li JJ; Song YM; Jiang B; Yang J; Yuan Y Hepatogastroenterology; 2014; 61(133):1207-12. PubMed ID: 25436284 [TBL] [Abstract][Full Text] [Related]
7. [Imaging in the diagnosis of colorectal liver metastases and extrahepatic abnormalities]. Bipat S; van Leeuwen MS; Oyen WJ; Planting AS; IJzermans JN; Stoker J Ned Tijdschr Geneeskd; 2008 Apr; 152(15):857-62. PubMed ID: 18512524 [TBL] [Abstract][Full Text] [Related]
8. [Evaluation of positron emission tomography by using F-18-fluorodeoxyglucose in diagnosis of recurrent colorectal cancer]. Kula Z; Szefer J; Zuchora Z; Romanowicz G; Pietrzak T Pol Merkur Lekarski; 2004; 17 Suppl 1():63-6. PubMed ID: 15603351 [TBL] [Abstract][Full Text] [Related]
9. The role of whole-body positron emission tomography with [18F]fluorodeoxyglucose in identifying operable colorectal cancer metastases to the liver. Lai DT; Fulham M; Stephen MS; Chu KM; Solomon M; Thompson JF; Sheldon DM; Storey DW Arch Surg; 1996 Jul; 131(7):703-7. PubMed ID: 8678767 [TBL] [Abstract][Full Text] [Related]
10. Clinical impact of FDG PET-CT in patients with potentially operable metastatic colorectal cancer. Briggs RH; Chowdhury FU; Lodge JP; Scarsbrook AF Clin Radiol; 2011 Dec; 66(12):1167-74. PubMed ID: 21867996 [TBL] [Abstract][Full Text] [Related]
11. PET/CT: will it change the way that we use CT in cancer imaging? Hicks RJ; Ware RE; Lau EW Cancer Imaging; 2006 Oct; 6(Spec No A):S52-62. PubMed ID: 17114079 [TBL] [Abstract][Full Text] [Related]
13. [Combined FDG PET/CT imaging for restaging of colorectal cancer patients: impact of image fusion on staging accuracy]. Strunk H; Bucerius J; Jaeger U; Joe A; Flacke S; Reinhardt M; Hortling N; Palmedo H Rofo; 2005 Sep; 177(9):1235-41. PubMed ID: 16123869 [TBL] [Abstract][Full Text] [Related]
14. Routine (18)F-FDG PET preoperative staging of colorectal cancer: comparison with conventional staging and its impact on treatment decision making. Kantorová I; Lipská L; Bêlohlávek O; Visokai V; Trubaĉ M; Schneiderová M J Nucl Med; 2003 Nov; 44(11):1784-8. PubMed ID: 14602860 [TBL] [Abstract][Full Text] [Related]
15. Preoperative evaluation of colorectal cancer using CT colonography, MRI, and PET/CT. Kijima S; Sasaki T; Nagata K; Utano K; Lefor AT; Sugimoto H World J Gastroenterol; 2014 Dec; 20(45):16964-75. PubMed ID: 25493009 [TBL] [Abstract][Full Text] [Related]
16. Use of a decision analysis model to assess the cost-effectiveness of 18F-FDG PET in the management of metachronous liver metastases of colorectal cancer. Lejeune C; Bismuth MJ; Conroy T; Zanni C; Bey P; Bedenne L; Faivre J; Arveux P; Guillemin F J Nucl Med; 2005 Dec; 46(12):2020-8. PubMed ID: 16330566 [TBL] [Abstract][Full Text] [Related]
17. Evaluating 90Y-glass microsphere treatment response of unresectable colorectal liver metastases by [18F]FDG PET: a comparison with CT or MRI. Wong CY; Salem R; Raman S; Gates VL; Dworkin HJ Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):815-20. PubMed ID: 12029557 [TBL] [Abstract][Full Text] [Related]
18. Preoperative staging of rectal cancer: pelvic MRI plus abdomen and pelvic CT. Does extrahepatic abdomen imaging matter? A case for routine thoracic CT. Adeyemo D; Hutchinson R Colorectal Dis; 2009 Mar; 11(3):259-63. PubMed ID: 18513197 [TBL] [Abstract][Full Text] [Related]
19. Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment. Niekel MC; Bipat S; Stoker J Radiology; 2010 Dec; 257(3):674-84. PubMed ID: 20829538 [TBL] [Abstract][Full Text] [Related]
20. Radiological staging of colorectal liver metastases. Ong KO; Leen E Surg Oncol; 2007 Jul; 16(1):7-14. PubMed ID: 17499498 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]